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Abstract
Objective To elicit patients’ preferences for the treatment of angina.
Design Angina patients were interviewed in order to elicit their
personal reasons underlying preferences for various treatment
options. Interviews followed a general repertory grid technique, in
which seven treatment options were presented to patients in triads.
Treatments considered ranged from medication to invasive revas-
cularization therapies, with a no treatment’ option.
Setting Two general practices in Norwich, Norfolk.
Subjects Twenty-one patients with diagnosed angina, which was
both mild and stable.
Main outcome measures Treatment preferences verbalized by
patients during interview, and the underlying reasons for these.
Results Attitudes voiced towards the range of treatments for angina
were diverse; 27 diﬀerent reasons underlying patients’ preferences
were identiﬁed. Patients’ preferences were largely justiﬁed by reasons
associated with the conditional eﬀectiveness or otherwise of treat-
ments. When presented with treatment triads, medication (drug)
treatments were over 2.5 times more likely to be chosen as a most
preferred option than invasive or surgical treatments. Although
surgical treatments were generally considered to be eﬀective’, it was
perceived that they were more appropriate for situations when the
condition became life-threatening. There were occasions, however,
when preferences were driven by other reasons, such as a desire to
avoid surgery because it was perceived negatively as invasive’ and
frightening’. Drug treatments were viewed as quick’, easy’ and
reversible. Personal experiences of the eﬀectiveness or otherwise of
treatments were frequently cited as reasons for stated preferences.
However, patients often commented that they would prefer the
doctor to make the decision about their treatment.
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Conclusions Patients choices among treatments was largely driven
by perceptions of their eﬀectiveness or otherwise. Although surgery
was perceived as eﬀective’ it was also seen as conditionally so,
dependent upon severity of the condition – which is not necessarily
the case, as the risks of adverse events and surgical complications
increase for emergency cases. As such, access to better information
about the eﬀectiveness and timeliness of interventions is needed.
Although respondents held anxieties about treatment, particularly
invasive or surgical treatments, fewer choices were driven by
emotional and lifestyle factors unrelated to eﬀectiveness’, such as
fear or ease of treatment.
Introduction
Information on patients’ preferences for treat-
ment options, where alternatives exist, is
sparse.1,2 A systematic review of the literature
on patients’ preferences in clinical decision
making reported relatively little literature on
the patients’ perspective, and focused mainly on
the challenges for doctors in involving patients
in decisions.3 The authors emphasized that:
Finding ways to elicit patients’ preferences is
therefore a considerable challenge’.3 The issue is
important for both patient care and research
methodology. Preference assessments are of
particular value in building up a patient-based
ethics of evidence’ when there is uncertainty
about when to provide more or less intensive or
invasive treatments to patients, and when issues
of health service prioritization are being deba-
ted. Preferences could theoretically inﬂuence
patients’ adherence to, and satisfaction with,
treatment, and thereby have some impact on
their health outcomes and on the cost-eﬀect-
iveness of health services.4–6 Patients’ prefer-
ences for treatment also have the potential for
contaminating unblinded randomized con-
trolled trials.7 The scarcity of information
about patients’ treatment preferences and the
acceptability of alternatives, and their eﬀects on
outcome, leads to the question of whether act-
ual informed consent for treatment is really an
illusion’.8 Where quality of life and life
expectancy issues are of relevance, people’s
informed preferences should be as important in
health care decision making as the body of
evidence on a procedure’s clinical eﬀectiveness
and costs.1
In the course of a pilot study to quantify the
treatment preferences of angina patients, over
20 patients took part in semi-structured inter-
views. These interviews provided insight into
the reasons underlying patients’ preferences
for treatment and forms the basis of this
article.
Methods
The sample
Angina patients were recruited from two general
practices in Norwich. The eligibility criteria
were: that patients should have been diagnosed
with angina within the past 5 years; that
patients’ angina was mild and stable’; that the
patients were not currently being considered for
invasive or surgical options; and that the
patients had either not had a cardiology referral
at all or that they had only seen a cardiologist
for post-diagnosis assessment without further
invasive intervention (a routine process in
Norwich with the availability of open-access
chest pain assessment clinics). A total of 21
patients were interviewed. Once patients had
responded to a letter of invitation from their
general practitioners (GPs), they were tele-
phoned by a researcher to arrange an interview
at their surgery. Ethical consent was obtained
from The Norwich District Ethics Committee.
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Materials used
Descriptions of seven diﬀerent potential treat-
ment options (three of which were drug-based,
three of which were invasive or surgical, and one
of which involved no treatment’) for angina
were produced for presentation to respondents
on pale-blue A4 laminated show cards, including
information about risks and beneﬁts. The lam-
inated show cards (available from the authors)
were not designed for use as a possible clinical
tool. The driver for the approach was scientiﬁc
research – to elicit angina patients’ views and
constructs regarding possible treatment options
in an objective and robust manner.
Each of the seven treatments was described
separately on an A4 laminated show card; they
were not of equal length. The print was large, to
help readability especially for older patients who
might have problems with vision. The cards
provided an objective description of the treat-
ments, and a description of the chances of their
success and possible side-eﬀects using the latest
available information. They provided informa-
tion and not advice. The information was pre-
sented simply, and was based on British Heart
Foundation patient literature, which was upda-
ted. This was the sole source of information on
the treatments provided. The cards were pre-
sented to the patients in groups of three.
The treatment options presented on the cards
were: no treatment (treatment 1); drug therapy
to treat symptoms only (treatment 2); drug
therapy to prevent occurrence of chest pain/
breathlessness (treatment 3); drug therapy to
prevent symptoms occurrence and reduce risk of
future heart attack (treatment 4); balloon angi-
oplasty (invasive treatment 5); coronary artery
bypass surgery (CABG) (invasive surgical
treatment 6); and keyhole surgery (invasive
surgical treatment 7). A further A4 laminated
card was designed, which gave a standard des-
cription of angina and summarized the interview
instructions for the patient.
A short questionnaire was also administered
that requested basic socio-demographic details
(age, sex, level of education, occupation, hous-
ing tenure), self perceived health status,9 use of
health services, and severity and impact of
angina.10
Interview rationale
The interview format was generally based upon
a repertory grid framework; a technique that has
been widely used in psychology, marketing and
consumer choice.11 In brief, respondents were
asked to consider preferences for a number of
items. The items are presented to the respond-
ents in threes (a triad) and they are asked for
their most and least preferred item and the rea-
sons for their choice. In this study the items were
seven angina treatments. From trial interviews,
oﬀering three triads (of treatments) to each
participant seemed reasonable. A randomization
method was then devised for oﬀering each of 20–
30 patients, three treatment triads from the
seven possible options. The random ordering of
triads chosen followed a balanced, incomplete
block’ design. The ﬁrst two triads contained six
diﬀerent treatments; the ﬁnal triad contained the
missing treatment and one other treatment from
each of the ﬁrst two triads. Therefore, in the 21
interviews conducted, each treatment was used a
total of 27 times. Furthermore, for 21 inter-
viewees receiving three triads, all combinations
of the seven options were presented a similar
number of times, and each patient considered
each of the seven options at least once.
Conducting the interviews
Interviews took place in the GPs’ consulting
rooms. The interviewer (NL), although not a
health professional’, was an experienced inter-
viewer with biomedical expertise and had been
thoroughly briefed by AB and SE regarding the
many issues surrounding the seven treatments.
Patients ﬁrst completed the small demogra-
phic and health status questionnaire with the
interviewer. Patients were then shown the A4
card containing the deﬁnition of angina and a
summary of what would happen next. It was
explained to patients that they would be pre-
sented with three diﬀerent triads of treatment
options for angina to consider and that these
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had been chosen at random prior to the inter-
view. This part of the interview was audio-taped
with the patients’ consent. The interviewer
emphasized the hypothetical nature of the situ-
ation to respondents. The task was then intro-
duced by the interviewer as follows: Imagine
that your angina symptoms were slightly worse
than they are now, and you went to your GP,
who gave you three and only three possible
treatment options. Which treatment would you
most prefer and why, and which one would you
least prefer and why?’ It was explained that this
process would be repeated three times (for three
triads), and the patient was then handed the ﬁrst
set of show cards to read through.
Ample time was given to the patients to read
the information. After they had read the cards
they were invited to ask questions about any-
thing on the cards, most declined as they stated
that they understood’ the treatments. Indeed
they all indicated that they had an understand-
ing’ of the diﬀerent treatments before they read
the cards. They all said that they had discussed
medical and surgical treatments with their doc-
tors at various times. Many of the concepts
mentioned on the cards were raised by the par-
ticipants during the interview (e.g. scarring
during CABG, the newness of the keyhole
technique, headaches from use of nitrates). How
reading the cards changed the participants
understanding’ of the seven treatments was not
addressed within this study. Providing the cards
did however ensure that all participants saw
exactly the same information. The use of the
cards both aided clarity and consistency, in that
it ensured that all the patients saw the same
deﬁnition.
The interviewer probed the patient’s reasons
for treatment preferences to get beyond super-
ﬁcial answers, and summarized, reﬂected back,
and paraphrased answers in order to ensure that
the reasons behind option choices were fully
explored. After the third triad, the interview
ended. The interviews were not formally timed,
but were between 30–60 min each, with most
lasting for approximately 45 min. Doing three
triads did not appear arduous for the patients. It
should be noted that these interviews were
semi-structured, and formed part of the reper-
tory grid exercise, and should not be confused
with qualitative interviews.
For every triad of treatment options pre-
sented to patients at the interview, the most
and least preferred option stated was noted.
During the study, a total of 63 triads were
presented to patients with each treatment fea-
turing 27 times.
Coding procedure
The interviewer and one other researcher each
listened to the tape recordings of the interviews
and recorded separately the key reasons behind
the preferences cited by each patient. The two
researchers then met twice to compare notes and
together developed an agreed list of reasons for
each patient. These were then agreed by the
research team. General themes were identiﬁed
across the diverse wording of reasons. A third
member of the research team subsequently lis-
tened to each audio-taped interview and tran-
scribed the elicited reasons for treatment
preferences, in order to provide insightful illus-
trations of the categorized data.
Results
Patient characteristics
Of the 21 patients, 13 were male and eight were
female. Their ages ranged from 43 (the only
person under 59 years) to 80 years (mean: 68.3;
standard deviation: 9.0; median: 70). Thus apart
from one patient, the respondents were elderly
or very elderly. Six patients had some form of
further education (obtaining mainly professional
qualiﬁcations), and the remainder had left
school between 14 and 16 years of age. Seven
patients had a professional occupation, and 19
patients were home-owners. Thus respondents
represented a fairly broad mix of socio-econo-
mic circumstances. Eleven respondents (52%)
stated that their angina limited their activities in
some way. When asked how their current health
was compared with other people your age’, 14%
said excellent’, 24% said very good’, 42–43%
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said good’, 10% said fair’ and only 10% said
poor’. Thus patients generally had a positive
attitude towards their health.
Patients’ preferences
Table 1 summarizes the treatment preferences
verbalized by the patients during the interview.
The no treatment’ option was selected 26 times
(of a maximum of 27), as the least preferred’
treatment within the triads presented.
One person however, did choose this as their
most preferred option in response to a triad
containing no treatment’ and two surgical
treatments. This particular patient (70+) was
adamant about not wanting any surgery.
Because all participants were patients’ de facto
and had been receiving some form of medical
treatment for some years, the sample was
probably biased towards this outcome. This
raises the possibility that patients with a fear of
an invasive or surgical treatment might opt for
no treatment’ as the lesser of two evils if given
an either/or choice.
The most preferred option was drug treatment
that oﬀered prevention of symptoms occurring
and provided some risk reduction against heart
attacks. During the presentation of the treat-
ment triads, this was chosen 21 times (of a
possible 27) as the most preferred treatment, and
it was never chosen as the least preferred option.
In total, the three drug treatments were over 2.5
times more likely to be chosen as a most pre-
ferred option compared with the three invasive
or surgical options. Again, there could be a
selection bias with these ﬁndings as all the par-
ticipants were already taking some drug regime
that was generally eﬀective as their angina was
stable.
Surgical or invasive treatments were 2.5 times
more likely to be chosen as a least preferred
option compared with drug therapies. CABG
was particularly unpopular, being chosen 14
times as the least preferred option. However, for
three patients, CABG was their most preferred
option within a triad. All these patients were
under 70 years and the triads all included the no
treatment’ option.
Reasons given by patients for their treatment
preferences
Table 2 lists the reasons patients gave for their
treatment preferences in order of frequency. We
identiﬁed 27 reasons, several of which were
quite frequently mentioned. In this section the
main reasons are given, illustrated with appro-
priate quotations from respondents in an
attempt to elucidate why they made their
treatment choices.
Worthless (n ¼ 21)
Worthless’ was the main reason that patients
gave for no treatment’ being their least pre-
ferred option. This reason (cited 21 times) was
the most common given throughout the study.
With no treatment at all you could just go (and)
have a heart attack and die. (003, male aged 70+,
non-professional, activities limited by angina)
If you’ve got choice you obviously need something
to help you get better from it, don’t you? (015,
female aged 70+, professional, activities limited by
angina)
That’s (no treatment) a no-brainer (013, male aged
<70, professional, activities not limited by angina)
Table 1 Frequency of patients’ preferences verbalised during
interview
Treatment number
Most
preferred
(n)
Least
preferred
(n)
1 ¼ No treatment 1 26
2 ¼ Drugs to treat symptoms 12 7
3 ¼ Drugs to prevent symptoms 10 3
4 ¼ Drugs to prevent symptoms
and reduce risk of heart attacks
21 0
5 ¼ Balloon angioplasty 6 4
6 ¼ CABG 3 14
7 ¼ Keyhole surgery 7 7
Drug treatments 43 10
Surgical treatments 16 25
No treatments 1 26
During the interviews, patients were asked to choose their most and
least preferred treatments from three random triads of seven treat-
ments. Each treatment was used a total of 27 times in the 21 inter-
views.
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Effective (n ¼ 18)
The next most common reason elicited was
eﬀective’. This was stated as a response to both
drug and invasive/surgical treatments. Most
typically it was voiced for drug treatments that
patients were already taking.
I know that (drug treatment) is eﬀective in my case,
so why do anything more? (021, female aged <70,
professional, activities limited by angina)
This reason is clearly the reverse of worth-
less’. Both indicated that the main priority of
most patients was to receive the best treatment
for their condition, irrespective of any other
factors. In the quote below, for example, it is
clear that, in spite of being scared of surgery, this
patient would choose this option as it provided
the best outcome:
If you had that (surgery) you wouldn’t worry
about whether one (angina attack) would come on.
I could be sitting here and it could come on...I’m
not that old, and I have four grandchildren
and...I’d like to be around for my grandchildren to
grow up...(I would want CABG) if it was going to
prolong my life... I’d be quite scared I think but
that’d (surgery) be the best option. (007, female
aged < 70, non-professional, activities limited by
angina)
Appropriate for severe symptoms (n ¼ 17)
It was clear that for some patients, there was no
one type of treatment that was always most
eﬀective, and that eﬀectiveness was seen as
contingent upon the severity of symptoms. That
is, respondents saw surgical treatments as highly
appropriate for severe symptoms, and several
Table 2 Reasons patients gave for
angina treatment preferences
Reason given/ranking Frequency
Angina
treatments
1 ¼ Worthless 21 1
2 ¼ Effective 18 2,3,4,5,6,7
3 ¼ Appropriate for severe symptoms 17 5,6,7
4 ¼ Risky 16 5,6,7
5 ¼ Bad effects from procedure 13 2,5,6,7
6 ¼ Invasive 10 5,6,7
7 ¼ Encouraged to have it by what I know 8 2,3,4,5,6
7 ¼ Frightening 8 1,5,6,7
7 ¼ Easy to do 8 2,3,4
7 ¼ Suitable for maintaining my lifestyle 8 2,3,4
11 ¼ Put-off by what I know personally 7 2,5,6,7
12 ¼ Suitable for old people 5 2,3,4
13 ¼ Quick to do 4 2,3,4
13 ¼ Too much anaesthetic 4 5,6,7
15 ¼ Pain-relieving 3 3,4
15 ¼ Experimental 3 7
17 ¼ Reversible 2 3,4
17 ¼ Convenient 2 2,4
17 ¼ Expensive for NHS 2 7
17 ¼ Likely to result in burden on carers 2 1,6
21 ¼ Too much time in hospital 1 6
21 ¼ Willing to change lifestyle to avoid having 1 6
21 ¼ Dependent on skills of others 1 7
21 ¼ Beneﬁcial for future 1 5
21 ¼ Understandable 1 3
21 ¼ Able to monitor 1 4
21 ¼ Unknown 1 7
The coded treatment preference reasoning for all 21 patients are given in order of frequency. The
associated treatment number which the coded reasons relate to are also shown (see Table 1 for
key).
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patients who opted for drug treatments also
commented that they would consider surgery as
a last resort and when it was unavoidable.
However, because their symptoms of angina
were stable, most participants could not (or did
not want to) imagine a time when their angina
was severe. In the introduction to the interview,
people were asked to imagine that their symp-
toms were slightly worse than at present. How-
ever, this did not appear to trigger any feelings
of a last resort situation’ in them. Indeed, 80%
of the patients felt their health was good to
excellent, even when compared with individuals
of their age who did not have angina.
I don’t like the sound of that (balloon angioplasty),
then again if it was the last thing to do they would
have to do it wouldn’t they? (018, female aged
70+, non-professional, activities limited by
angina)
I think I would put things (surgery) oﬀ till as late
as you can like keyhole surgery...till I thought my
life was being completely dominated by angina
attacks. I think it’s got a way to go before that
happens.’ (021, female aged <70, professional,
activities limited by angina)
But that’s (surgery) something I would consider if I
found that I was not able to enjoy my life at all.
(021, female aged <70, professional, activities
limited by angina)
(My least preferred is) drugs. The easy option
frankly. I think if you’re going to grasp the net-
tle, as it were, it’s got to be (surgery). Yeah...let’s
get it over with. Taking into eﬀect my age group.
The older you get the less responsive I think
you’ll be to any treatment...the older you get the
more risk of not surviving the damn thing... (012,
male aged <70, professional, activities limited by
angina)
Riskiness of invasive/surgical treatments
(n ¼ 16)
This reason was solely given as a response to the
invasive and surgical options (angioplasty,
CABG, keyhole surgery) and reﬂected the fears
and uncertainties patients held for such treat-
ments. In a sense, it also reﬂected the issue of
eﬀectiveness, but from the negative side (risks
instead of beneﬁts). Patients often elucidated
further why they considered one option riskier
than another. Table 2 shows their coded rea-
sons. For example, they referred to the uncer-
tainty of a treatment [using terms/concepts such
as unknown experience’ (n ¼ 1), dependent on
the skills of others (1), experimental’ (n ¼ 3), or
identifying a speciﬁc risk factor, such as anaes-
thetic’ (n ¼ 4)]:
...there’s always a risk with surgery...With surgery
there’s always that doubt, even with keyhole sur-
gery, or any type of surgery if you have to go under
the anaesthetic. (003, male aged 70+, non-pro-
fessional, activities limited by angina)
Bypass surgery [least preferred], it would be an
unknown quantity (021, female aged < 70,
professional, activities limited by angina)
Bad effects from procedure (n ¼ 13)
One relatively important concern aﬀecting
treatment preference raised by patients was,
essentially, the issue of side-eﬀects. This reason
was mainly attributed to the consequences of
surgical operations, such as painful and disﬁg-
uring scars and the length of time needed to
recover. However, adverse eﬀects from the
nitrate spray treatment were also mentioned:
I gear the pace so I don’t have to use it (nitrate
spray). I don’t like it (because of side eﬀects). I gear
any activity, even walking the dog or anything like
that, you know, the pace, so I don’t have to use
that. As soon as I feel the tightness start to come I
slow down. I hate using the stuﬀ now. [012, male
aged <70, professional, activities limited by
angina)
The scars (from CABG) will be painful and I’ve
seen (from a friend) that the leg wound could be
diﬃcult to heal (013, male aged <70, professional,
activities not limited by angina)
Invasive (n ¼ 10), frightening (n ¼ 8)
Patients stated that the very invasiveness of the
invasive/surgical procedures (n ¼ 10) and the
frightening nature of these (n ¼ 8), drove their
choices. Upon probing, this reason seemed to
reﬂect a strong reluctance to be physically cut or
have their bodies physically interfered with.
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I’d stick with the least invasive..., till intervention
was necessary....I would always go for the least
invasive things (020, male aged < 70, professional,
activities not limited by angina)
Positive (n ¼ 8) and negative (n ¼ 7)
personal knowledge
The decisions of patients seemed to be partic-
ularly inﬂuenced by their existing knowledge
and experiences (personal, or experiences of
close others) (encouraged to have it by what I
know’ n ¼ 8; put oﬀ by what I know personally
n ¼ 7). This personal relevance’ could work
both positively or negatively. For example,
patients who had been given drugs that worked
for them, or had known a signiﬁcant other who
had undergone a successful surgical treatment,
were more inclined to choose these options.
Conversely, bad experiences (usually of surgical
treatments) – either personal or of a signiﬁcant
other – would put them oﬀ such options. For
example:
We’ve lost a cousin with that one (CABG), so that
puts me oﬀ straight away, you know. He came
home alright,..., but then within six months he
passed away (collapsed with a heart attack). (015,
female aged 70+, professional, activities limited by
angina)
I’m against surgery chieﬂy because I’ve experi-
enced people in the family who’ve had it (surgery),
not for this complaint (angina) but other com-
plaints, and they haven’t survived.... (004, male
aged 70+, non-professional, activities not limited
by angina)
..I do know somebody who had this (angioplasty)
done and she’s perfect. And I think that gave me a
boost...same age as I am....When I saw her,
before..., she was really out of breath like that
(pants)...you know, and she said she was waiting to
go to have this (angioplasty) done. I saw her about
a month after she’d had this done and she’d gone
back to work. She’s riding a bike!... (016, female
aged 70+, non-professional, activities not limited
by angina)
[Prefers drugs.] Well, I’m ﬁnding this way suc-
cessful at the moment. (015, female aged 70+,
professional, activities limited by angina)
Other reasons cited associated with medication
options
Several other reasons patients gave for choosing
drug regimes shared common themes, and
included: easy to do’ (n ¼ 8), suitable for
maintaining current lifestyle’ (n ¼ 8), suitable
for old people’ (n ¼ 5), quick’ (n ¼ 4) con-
venient’ (n ¼ 2) reversible’ (n ¼ 2), able to
monitor’ (n ¼ 1) and understandable’ (n ¼ 1).
Taking medication reﬂected the immediate path
of least resistance, requiring the smallest phys-
ical and emotional input and for these, pre-
dominantly elderly, patients (who are already
taking pills daily) involved making no changes
to their life at all. These patients were familiar
with drugs. Medication, they felt currently
worked for them, they felt it was safe, they
understood it and it was perceived to be con-
trollable by them. These reasons were diamet-
rically opposed to those such as invasive’,
frightening’ and risky’ which were mentioned
earlier.
I know that (drugs), it’s easy to understand and I
can monitor it myself to a degree. I mean it’s what
I’ve been used to doing for quite a few years...Stick
with what you know, yes. (020, male aged < 70,
professional, activities not limited by angina)
There’s not that much risk with drugs as you can
always come oﬀ the drugs and change them.....
(003, male aged 70+, non-professional, activities
limited by angina)
It’s (drugs: nitrate spray) quite quick isn’t it. That
do relieve pain (017, female aged <70, non-
professional, activities limited by angina)
Involvement in decision making
Finally, while a question was not speciﬁcally
asked about preference for involvement in
decision making at the pilot stage, patients often
commented that they would prefer the doctor to
make the treatment decision.
It would be likely that I would accept the (doctor’s)
evidence what the best option was. I would cer-
tainly want to be involved in the decision making
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in some way. I wouldn’t want to just take their
word...I’d want to know why, but I think it’s
probably unlikely that I would go against (doctor’s
advice). (006, male aged <70, professional, activ-
ities not limited by angina)
I don’t see any point in going to the doctor (if) you
don’t take any notice of what they (say). That’s
what they’re there for. (010, male aged 70+, non-
professional, activities limited by angina)
If the cardiologist thought I ought to have that
(surgery) then I would accept it. The cardiologist
said (to me) I want you to make up your mind
whether to have this test. But I felt really she ought
to advise me as to whether she thought it would be
better for me.’ (001, female aged 70+, non-pro-
fessional, activities not limited by angina)
Discussion
Patients’ preferences were largely driven by
patients’ desire for the most eﬀective’ treatment
that would have greatest beneﬁt for their life and
health. Their views on the range of invasive to
less invasive treatments for angina were, how-
ever, diverse, and seemed to reﬂect diﬀerences in
belief about the relative and contingent eﬀect-
iveness of the diﬀerent treatments. Thus, while
surgical treatments were generally considered to
be eﬀective’, they were often perceived negat-
ively, and to be more eﬀective when symptoms
were severe, and so to be avoided or delayed
until the condition became life-threatening. But
the latter situation is actually more risky for the
patient in terms of the greater risk of adverse
eﬀects and complications of urgent or emer-
gency surgery. It is unclear to what extent this
perception was a consequence of lack of know-
ledge, and to what extent it is driven by other
emotional and lifestyle concerns. For example,
surgery was commonly described as invasive’
and frightening’.
Patients’ fears of surgery were often rein-
forced by previous negative experiences. Patient
choices were predominantly being driven by
considerations of the relative eﬀectiveness/
worthlessness of treatments. However, other
factors such as lifestyle (e.g. convenience) and
emotions (e.g. fear) were involved in their
choices and these results raise the question of
how will doctors respond to the potential scen-
ario whereby patients, on a fairly large scale,
want the least (or a less) eﬀective treatment that
may also be less cost-eﬀective for the health
service in the longer term?12 However, many
respondents indicated that they preferred the
doctor to make the treatment decision. This is an
area where better information for patients, and
access to patient support groups, on the eﬀect-
iveness and timeliness of interventions, as well as
clearly presented, simple information about
risks, is needed.
This study clearly needs to be repeated with a
larger sample of patients and should include
other patient groups such as younger suﬀerers
and those with treatment experiences other than
medication. Use of a larger sample would enable
more detailed analysis of diﬀerences between
sample subsets. For example, our limited data
was suggestive that fear of surgery was more
prevalent among women and patients aged 75
and over, but this needs veriﬁcation. This is an
important issue because research in the UK has
shown that cardiac patients aged 75 years and
over have more severe coronary disease than
younger patients but are more likely to be trea-
ted medically rather than surgically.13,14 These
diﬀerences have been labelled as ageist.15
The richness of the more qualitative data pre-
sented here needs to be supported by more
quantitative studies using questionnaires. This
would enable analysis with other relevant varia-
bles (e.g. personality: extroversion, risk-taking;
disability; health service experiences; social
expectations and quality of life).Modelling is also
required in order to assess the impact on health
outcomes and costs of health care of incorpor-
ating (informed) patients’ preferences into clinical
decision making. If younger patients’ preferences
for surgery were acted upon clinically in a timely
manner, especially before patients’ fears of sur-
gery potentially increased with older age, then
invasive interventions (e.g. bypass surgery) may
be likely to lead to a longer period of healthier,
better quality of life – as well as reducing the need
for invasive surgerywhenpatients are older and, if
co-morbidity is present, more at risk of adverse
events. Eliciting patients’ preferences is important
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given that the balance of evidence about the
eﬀectiveness of a therapy is rarely suﬃcient to
eliminate uncertainty.16 Then the question Do
people want it’ 17 can be addressed in a rigorous
manner and the body of knowledge on public
acceptability of health technologies advanced.
It is hoped that the information presented
here will be informative for clinicians, and
helpful in their interactions with angina patients.
This is particularly important as many patients
stated that, despite their stated preferences, they
would still follow whatever advice their doctors
gave them. The use of laminated show cards was
not intended for use as a clinical tool, but the
issue of whether doctors could use them with
patients to facilitate any joint decision-making
process is a question for further research.
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